Navigation Links
Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
Date:1/22/2008

patients co-infected with HCV and HIV.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to the risk that the company will experience delays or difficulties in enrolling patients in the study and the risk that the results from this trial will not be consistent with the results of prior trials or preclinical studies. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in devel
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Fla. , March 6, 2015 ... special validation from Intuitive Surgical, the manufacturer of ... their Triton-36 Instrument Cleaning System. This approval reflects ... standards in cleanliness currently in place for the ... special validation for reprocessing robotic surgical instruments for ...
(Date:3/6/2015)... 2015 Troyen A. Brennan, M.D., M.P.H., Executive ... (NYSE: CVS ), will speak before the ... D.C. today.  Brennan will outline ways pharmacy ... care cost and quality as the overall health care ... national pharmacy chain to stop selling tobacco in support ...
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
Breaking Medicine Technology:Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2
(Date:3/6/2015)... Sanjay Gupta, MD, CNN’s Emmy award-winning ... at ATA 2015, the American Telemedicine Association's (ATA) ... world’s largest telemedicine, telehealth and mHealth meeting. , ... for several of CNN’s headlining programs including New ... DuPont Award winning WEED series. He has created ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 ... the leader in the natural products coffee drinks category, ... 100 Cleanest Packaged Foods Awards for its Double ... puts packaged foods to the test to find the ... they must “taste absolutely delicious.” , “As a company ...
(Date:3/6/2015)... Follow us on LinkedIn ... crowns, abutments and dentures are used to provide relief ... and missing teeth. The growth in the global market ... an aging global population, expanding number of edentulous people ... 65+ population being edentulous or completely toothless, there is ...
(Date:3/6/2015)... 2015 Parents need to start the ... substance use disorders. School programs like DARE, or Drug ... NOPE, or Narcotics Overdose Prevention and Education has already ... Healthline News on Feb. 27th. As teens continue ... drugs, drug prevention proponents are lobbying Florida to pass ...
(Date:3/6/2015)... PA (PRWEB) March 06, 2015 As ... of a national shortfall of 90,000 doctors by 2025 ... Susquehanna Health (SH) is proactively preparing by ... recruitment and patient access. , Several factors including ... increasing number of insured under the Affordable Care Act ...
Breaking Medicine News(10 mins):Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2Health News:Prevention Magazine Names Califia Farms Winner of 2015 Cleanest Packaged Food Award 2Health News:Prevention Magazine Names Califia Farms Winner of 2015 Cleanest Packaged Food Award 3Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4
... 4, 2011 Findings by UT Southwestern Medical Center researchers ... transplants in patients with blood cancers such as leukemia, lymphoma ... Cell Stem Cell , showed for the first time that ... immune response that leads to transplant rejection. It also opens ...
... on Aug. 3 announced that they were among the first ... lung transplant, using a device invented by two university faculty ... "The device helps patients get oxygen into their blood by ... and oxygenates the blood before returning it to the heart, ...
... , THURSDAY, Aug. 4 (HealthDay News) -- People with a rare ... mutation, according to a new study. The findings, published ... of Human Genetics , could shed light on how fingerprints ... unknown aspects of human biology, the researchers pointed out. "We ...
... the risk of an acute attack of pancreatitis, but wine or ... a study published online by BJS, the British Journal of ... followed 84,601 people from 46 to 84 years of age from ... ten years. During that time 513 developed acute pancreatitis. "Our ...
... -- The cost of dealing with health insurers and payers ... Canadian physicians, a new study finds. The extra time ... $82,975 for U.S. physicians and $22,205 for physicians in the ... University of Toronto and colleagues. U.S. doctors spend an ...
... HealthDay Reporter , WEDNESDAY, Aug. 3 (HealthDay News) ... cancer and better evaluate a patient,s treatment options, researchers say. ... can use to help them decide whether it,s appropriate to ... researcher Dr. Scott Tomlins, a pathology resident at the University ...
Cached Medicine News:Health News:New use of artificial lung device pioneered at University of Kentucky 2Health News:Gene Mutation Can Leave People Without Fingerprints 2Health News:Drinking just 1 measure of spirits increases the risk of acute pancreatitis 2Health News:Urine Test Might Help Predict Prostate Cancer Risk 2Health News:Urine Test Might Help Predict Prostate Cancer Risk 3
... new age of non-surgical facial contouring materials. ... long-term results for various applications with exceptional ... superior versatility for a wide variety of ... saves time and money for both you ...
... Anti-Cellulite Treatment is clinically proven to reduce ... This patented cream-gel formula combines Retinol, the ... Extract and Caffeine. It works deep within ... and reduce bumpy appearance. Fast absorbing, it ...
... effectively delivers clinically proven aminophylline directly to ... Topical fat reduction with the aminophylline containing ... and an increase in the firmness of ... into the skin where it causes the ...
A device combining the "palpate & roll technique to vacuum massage, innovation dedicated to efficiency....
Medicine Products: